Screener/Healthcare/Biotechnology

TARS

Tarsus Pharmaceuticals, Inc.NASDAQ
$62.91-1.22 (-1.90%)
Mid CapHealthcareFastest GrowingLow Beta
$38.51
$85.25
$61.51
$66.20
EPS (TTM)$-1.61
P/E Ratio—
Dividend Yield—
Market Cap$2.73B
Volume238K
Prev Close$64.13
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q4 '25$151.7M-$8.4M$-0.19—-5.5%
Q3 '25$118.7M-$12.6M$-0.30—-10.6%
Q2 '25$102.7M-$20.3M$-0.48—-19.8%
Q1 '25$78.3M-$25.1M$-0.64—-32.1%
Q4 '24$66.4M-$23.1M$-0.59—-34.8%
Q3 '24$48.1M-$23.4M$-0.61—-48.7%
Q2 '24$40.8M-$33.3M$-0.88—-81.6%
Q1 '24$27.6M-$35.7M$-1.01—-129.4%
Get Your Daily Market Recap